A novel minigene scaffold for therapeutic cancer vaccines

by Aurisicchio, Luigi, Fridman, Arthur, Bagchi, Ansuman, Scarselli, Elisa, La Monica, Nicola, Ciliberto, Gennaro
Published 2014

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study

by Aurisicchio, Luigi, Fridman, Arthur, Mauro, David, Sheloditna, Rose, Chiappori, Alberto, Bagchi, Ansuman, Ciliberto, Gennaro
Published in J Transl Med (2020)

An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform

by Fridman, Arthur, Finnefrock, Adam C., Peruzzi, Daniela, Pak, Irene, La Monica, Nicola, Bagchi, Ansuman, Casimiro, Danilo R., Ciliberto, Gennaro, Aurisicchio, Luigi
Published 2012

High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8(+) T-Cell Expansion but Improved Virus Control

by Davenport, Miles P., Zhang, Lei, Bagchi, Ansuman, Fridman, Arthur, Fu, Tong-Ming, Schleif, William, Shiver, John W., Ribeiro, Ruy M., Perelson, Alan S.
Published 2005

Phase 1 studies of the safety and immunogenicity of electroporated HER2/CEA DNA vaccine followed by adenoviral boost immunization in patients with solid tumors

by Diaz, Claudia Marcela, Chiappori, Alberto, Aurisicchio, Luigi, Bagchi, Ansuman, Clark, Jason, Dubey, Sheri, Fridman, Arthur, Fabregas, Jesus C, Marshall, John, Scarselli, Elisa, La Monica, Nicola, Ciliberto, Gennaro, Montero, Alberto J
Published 2013